The ABHD10 Knockout A-549 Polyclonal Cells product comprises a polyclonal population of human A-549 lung epithelial cells subjected to CRISPR/Cas9-mediated disruption of the ABHD10 gene. This loss-of-function model enables investigation of ABHD10-dependent processes without the constraints of single-cell clonal selection, maintaining genetic heterogeneity that more closely reflects the complexity of tumor cell populations. The polyclonal format is particularly suited for studies in which population-level responses to gene disruption are of primary interest, such as metabolic profiling or drug-sensitivity screening.
The parental A-549 cell line originates from human lung adenocarcinoma and serves as a widely utilized model of alveolar basal epithelial cells. These cells exhibit characteristic features of adenocarcinomic transformation, including rapid proliferation, altered metabolism, and the capacity for invasion. Their epithelial origin and well-characterized signaling networks make A-549 cells a relevant platform for dissecting the molecular mechanisms underlying non-small cell lung cancer, particularly in the context of mitochondrial function and lipid metabolism.
ABHD10 encodes a mitochondrial serine hydrolase that functions as a lysophospholipase, catalyzing deacetylation of lysophosphatidylserine (lyso-PS) to glycerophosphoserine. Regulated by PPARGC1A, NFE2L2, and mitochondrial stress signals, the enzyme interacts with lyso-PS and mycophenolic acid acyl-glucuronide, localizing to mitochondrial membrane lipids. ABHD10-dependent control of lyso-PS levels influences G protein-coupled receptor-mediated signaling and intersects with PS-PLA1 and mitochondrial respiratory chain complexes. Thus, ABHD10 integrates lipid signaling with mitochondrial oxidative phosphorylation and xenobiotic glucuronidation.
In the A-549 lung adenocarcinoma background, disruption of ABHD10 perturbs lyso-PS metabolism, impacting mitochondrial function and tumor cell behavior. The knockout model may reveal metabolic vulnerabilities linked to the gene??s role in mitochondrial dysfunction-related disorders. Altered lyso-PS signaling could affect proliferation, migration, and apoptosis, offering insights into lipid-mediated adenocarcinoma progression. The polyclonal population mirrors intratumoral heterogeneity, strengthening translational relevance.
This knockout product is designed for a range of advanced research applications, including quantitative analysis of lyso-PS by LC-MS/MS, assessment of mitochondrial respiration using Seahorse flux analyzers, and investigation of mycophenolic acid metabolism and toxicity. It is also suitable for Western blotting, RT-qPCR profiling of metabolic genes, and functional assays such as cell proliferation, migration, invasion, ATP measurement, and apoptosis detection. Researchers studying lysophospholipid signaling in lung cancer, mitochondrial dysfunction in tumor metabolism, or drug toxicity screening will find this model a valuable tool. For additional information or technical support, please contact Ascent Research.
